Why This Comparison Matters
Emsculpt Neo and PHYSIQ sit in the same body contouring category but take different approaches. Emsculpt Neo (BTL Industries) uses HIFEM+ (High-Intensity Focused Electromagnetic) + Synchronized RF while PHYSIQ (Cartessa Aesthetics) uses STEP (Sequential Thermal & Electrical Pulse) technology. Both received FDA clearance (2020 and 2022 respectively) and both are actively sold in the US market. The decision between them is rarely about which is objectively better. It's about which fits your specific practice.
Physicians end up comparing these two devices when they're shopping in the $90,000-$175,000 to $80,000-$120,000 price range and want a category leader. Both devices are commonly recommended by sales reps from competing manufacturers, which means physicians often hear inflated claims about one and dismissive claims about the other. This comparison strips out the marketing and looks at pricing, mechanism, evidence, and practice fit side by side.
The Verdict
Choose Emsculpt Neo if your practice prioritizes BTL Industries's ecosystem, brand recognition, or specific clinical advantages. Practices wanting the most versatile body contouring platform with both aesthetic and medical applications. High-volume med spas that can fill treatment slots. The pros that matter most: Simultaneous fat reduction + muscle building (unique combo); FDA-cleared for medical conditions, expanding addressable market. The biggest tradeoff to accept: Highest price point in the category ($90K-$175K new).
Choose PHYSIQ if Cartessa Aesthetics's positioning fits better. Med spas wanting a competitive body contouring platform at a lower price point than Emsculpt Neo with multi-zone treatment capability. The pros that matter most: 4 independent applicators (treat 4 zones simultaneously); Lower consumable costs than CoolSculpting. The biggest tradeoff to accept: Newer platform, less clinical evidence than Emsculpt Neo or CoolSculpting.
For a practice with limited capital that needs maximum flexibility, used pricing tilts the math. Emsculpt Neo used units run $50,000-$135,000; PHYSIQ used units run $40,000-$70,000. For practices with strong patient flow already, the device that integrates with your existing platforms is usually the right answer even if its standalone specs are slightly weaker. For practices building a category from scratch, brand recognition and patient demand matter more than raw clinical specs. Look at which device patients are already asking for in your market before signing a contract.
Frequently Asked Questions
Which is more expensive, Emsculpt Neo or PHYSIQ?
Emsculpt Neo runs $90,000-$175,000 new and $50,000-$135,000 used. PHYSIQ runs $80,000-$120,000 new and $40,000-$70,000 used. Per-session pricing is $850+ (BTL-mandated minimum) for Emsculpt Neo and $500-$1,000 for PHYSIQ. Annual operating costs (consumables plus maintenance) typically run 5-15% of purchase price for both devices. The right financial comparison includes total cost of ownership over 5 years, not just sticker price.
Which has better clinical evidence, Emsculpt Neo or PHYSIQ?
Emsculpt Neo clinical evidence: 300+ published studies. Largest evidence base in the body contouring category. 2026 JAMA Dermatology study (n=340) showed 22.4% fat reduction sustained at 6 months. PHYSIQ clinical evidence: Emerging. Multiple conference presentations, limited peer-reviewed publications vs established competitors. Evidence quality is not about study count alone. Look at sample sizes, blinded evaluators, independence from manufacturer funding, and outcome durability. Older devices in the same category usually have stronger evidence because they've been studied longer.
Is Emsculpt Neo or PHYSIQ more popular in dermatology practices?
Both Emsculpt Neo and PHYSIQ are commonly used in dermatology, plastic surgery, med spa practices. Market share in any given category shifts year to year. BTL Industries and Cartessa Aesthetics both maintain active sales forces in the US. Ask other physicians in your specialty which platform they're using and why. Peer references in your local market matter more than national market share data.
Are there safety concerns with Emsculpt Neo or PHYSIQ?
Both devices are FDA cleared and have established safety profiles. Emsculpt Neo has these documented concerns: Highest price point in the category ($90K-$175K new). PHYSIQ has: Newer platform, less clinical evidence than Emsculpt Neo or CoolSculpting. Physicians should monitor FDA MAUDE reports for both devices before purchase. Adverse event trends matter because they signal problems that may not appear in marketing materials. Any device with a sudden spike in MAUDE filings deserves closer scrutiny.
Can I use Emsculpt Neo and PHYSIQ in the same practice?
Some practices run both devices, especially when they target different patient segments or treatment areas. The downside is duplicated training, parallel consumable inventories, and potential cannibalization between platforms. The upside is broader marketing claims and the ability to switch patients between platforms if one doesn't deliver expected results. Most practices choose one and commit to mastering it rather than splitting volume.
What's the resale value comparison between Emsculpt Neo and PHYSIQ?
Used Emsculpt Neo sells for $50,000-$135,000 on the secondary market. Used PHYSIQ sells for $40,000-$70,000. Resale values depend on age, software version, applicator condition, and remaining warranty. Devices with strong installed bases hold value better. Devices with active safety signals or declining manufacturer financial health depreciate faster. Resale value should be a factor in any device purchase, especially if practice plans might change in 3-5 years.
Emsculpt Neo vs PHYSIQ: which is better for dermatology practices in 2026?
For dermatology practices specifically in 2026, the choice between Emsculpt Neo and PHYSIQ depends on three factors: existing equipment compatibility (does the new device integrate with what you already run), patient mix and treatment volume (high-volume practices typically benefit from Emsculpt Neo's simultaneous fat reduction + muscle building (unique combo) while lower-volume practices often prefer PHYSIQ's 4 independent applicators (treat 4 zones simultaneously)), and total cost of ownership over 5 years including consumables and maintenance. Run the side-by-side TCO analysis with realistic patient volume projections before committing to either platform.
Emsculpt Neo vs PHYSIQ: 2026 update on features and clinical evidence?
As of April 2026, both Emsculpt Neo and PHYSIQ continue commercial availability from BTL Industries and Cartessa Aesthetics respectively. Recent updates worth tracking: software releases, new applicator launches, expanded FDA labeling indications, and new peer-reviewed clinical evidence publications. Manufacturer financial stability also matters for long-term support and parts availability. Both manufacturers share business updates periodically that inform the long-term outlook for each device.
How do I choose between Emsculpt Neo and PHYSIQ for my practice?
Use a structured decision framework: list 5-7 must-have requirements specific to your patient mix and practice economics, score Emsculpt Neo and PHYSIQ against each requirement on a 1-5 scale, weight the requirements by importance, then sum the weighted scores. The platform that scores meaningfully higher (10%+ gap) is the right choice. If the scores are within 10%, secondary factors decide: manufacturer relationship, financing terms, training availability, and resale value. Avoid choosing based on feature breadth alone because most devices in this category have similar feature checkboxes. The differentiation is in workflow fit, treatment results, and total cost over 5 years.
Are there better alternatives to Emsculpt Neo or PHYSIQ in the body contouring category?
In the body contouring category, Emsculpt Neo and PHYSIQ are often the leading platforms but other alternatives may fit specific practice profiles better. Other category options include emsculpt-classic, coolsculpting-elite, sculpsure. Run a 4-platform shortlist evaluation rather than a 2-platform binary because hidden alternatives sometimes outperform on the metrics that matter most to your specific practice.